| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
63,997 |
59,162 |
$2.57M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
41,845 |
38,708 |
$2.33M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12,719 |
12,471 |
$999K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
11,439 |
11,333 |
$614K |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
700 |
695 |
$511K |
| 59426 |
|
489 |
487 |
$353K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
2,466 |
874 |
$299K |
| 99215 |
Prolong outpt/office vis |
3,215 |
3,065 |
$248K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,526 |
5,712 |
$142K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,872 |
1,862 |
$123K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
3,078 |
1,559 |
$119K |
| 99233 |
Prolong inpt eval add15 m |
2,043 |
1,035 |
$111K |
| 99205 |
Prolong outpt/office vis |
950 |
927 |
$99K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,151 |
1,144 |
$85K |
| 99223 |
Prolong inpt eval add15 m |
787 |
696 |
$84K |
| 20610 |
|
2,926 |
2,815 |
$79K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,971 |
1,947 |
$78K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,179 |
1,170 |
$74K |
| 59430 |
|
463 |
462 |
$74K |
| 99222 |
Initial hospital care, per day, moderate complexity |
889 |
801 |
$61K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,591 |
3,542 |
$45K |
| 95886 |
|
1,378 |
1,167 |
$43K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
624 |
624 |
$39K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,338 |
1,262 |
$38K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
517 |
504 |
$36K |
| 59025 |
Fetal non-stress test |
1,902 |
771 |
$36K |
| 76801 |
|
987 |
969 |
$34K |
| 99254 |
|
390 |
360 |
$32K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
864 |
863 |
$31K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
584 |
553 |
$29K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
425 |
425 |
$26K |
| 93971 |
|
1,827 |
1,779 |
$23K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
3,818 |
3,386 |
$18K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
539 |
534 |
$18K |
| 92557 |
|
796 |
794 |
$17K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
353 |
352 |
$15K |
| 95910 |
|
231 |
227 |
$14K |
| 93970 |
|
681 |
666 |
$13K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
178 |
175 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
492 |
488 |
$12K |
| 92567 |
|
1,303 |
1,302 |
$12K |
| 76830 |
Ultrasound, transvaginal |
343 |
337 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,247 |
1,143 |
$11K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
105 |
105 |
$11K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
151 |
151 |
$10K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
115 |
115 |
$10K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
314 |
210 |
$9K |
| 52000 |
|
124 |
123 |
$9K |
| 99385 |
|
130 |
128 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
574 |
566 |
$7K |
| 73564 |
|
1,024 |
1,018 |
$7K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
71 |
71 |
$6K |
| 94726 |
|
718 |
718 |
$5K |
| 73110 |
|
799 |
694 |
$5K |
| 99442 |
|
224 |
217 |
$5K |
| 94060 |
|
694 |
691 |
$5K |
| 47562 |
|
12 |
12 |
$5K |
| 99406 |
|
697 |
675 |
$4K |
| 94729 |
|
775 |
775 |
$4K |
| 94010 |
|
774 |
760 |
$4K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
177 |
140 |
$4K |
| 81003 |
|
2,213 |
2,160 |
$4K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
265 |
258 |
$3K |
| 73030 |
|
554 |
538 |
$3K |
| 73610 |
|
411 |
366 |
$3K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
93 |
64 |
$3K |
| 73562 |
|
336 |
332 |
$3K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
144 |
139 |
$3K |
| 77427 |
|
29 |
12 |
$3K |
| 99443 |
|
114 |
110 |
$3K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
25 |
25 |
$3K |
| 93227 |
|
163 |
161 |
$2K |
| 90837 |
Psychotherapy, 53 minutes with patient |
41 |
25 |
$2K |
| 73130 |
|
291 |
264 |
$2K |
| 81025 |
|
354 |
351 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
150 |
150 |
$2K |
| 93922 |
|
262 |
255 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
83 |
71 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
318 |
297 |
$2K |
| 95811 |
|
27 |
27 |
$2K |
| 97597 |
|
94 |
68 |
$2K |
| 73630 |
|
160 |
151 |
$2K |
| 93018 |
|
168 |
167 |
$1K |
| 98966 |
|
579 |
536 |
$1K |
| 76818 |
|
40 |
25 |
$1K |
| G9002 |
Coordinated care fee, maintenance rate |
120 |
114 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
50 |
50 |
$1K |
| 93000 |
|
149 |
148 |
$1K |
| 73502 |
|
134 |
129 |
$904.32 |
| 93880 |
|
40 |
40 |
$903.20 |
| 51798 |
|
120 |
118 |
$876.99 |
| 71271 |
|
20 |
20 |
$660.22 |
| 20611 |
|
14 |
12 |
$542.85 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
28 |
28 |
$508.93 |
| 95908 |
|
14 |
14 |
$499.59 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
48 |
46 |
$460.05 |
| 95251 |
|
24 |
24 |
$445.77 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
343 |
340 |
$369.07 |
| 71250 |
|
12 |
12 |
$364.93 |
| 99441 |
|
36 |
35 |
$363.68 |
| 98967 |
|
44 |
44 |
$291.00 |
| 73140 |
|
16 |
16 |
$283.26 |
| J3490 |
Unclassified drugs |
56 |
54 |
$178.81 |
| 90688 |
|
12 |
12 |
$178.40 |
| 73080 |
|
16 |
15 |
$145.77 |
| 73560 |
|
12 |
12 |
$57.48 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
59 |
56 |
$40.77 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
15 |
15 |
$0.00 |
| 0502F |
|
19 |
12 |
$0.00 |
| 99070 |
|
135 |
129 |
$0.00 |